Press releases
- GSK showcases progress from the DREAMM clinical trial program in multiple myeloma at the 2021 ASH Annual Meeting
- GSK and Vir Biotechnology announce United States government agreements to purchase sotrovimab, a COVID-19 treatment
- Primary endpoint met in COMET-TAIL Phase III trial evaluating intramuscular administration of sotrovimab for early treatment of COVID-19
Tweets from GSK US
-
GSKUS @GSKUS
Judy Stewart, SVP and Head of US Vaccines, shares why it’s so important to improve routine immunization rates and address disparities in vaccination. Learn more in this clip and go Behind the science for the full video: gsk.to/3oXSMOD
about 6 days ago
-
GSKUS @GSKUS
The first step towards managing #COPD is advocating for a better treatment plan – and it starts with reminding patients that they are not to blame for their diagnosis. This #COPDAwarenessMonth, learn more about how to #ShakeCOPDStigma:
about 6 days ago -
GSKUS @GSKUS
Recently, our CEO Emma Walmsley spoke with Matthew Herper from @statnews about our unique research and development approach in RSV. #STATSummit Learn more about RSV here: gsk.to/3DIINmj]
about 6 days ago
